If You Invested $1,000 in Encompass Health Corp (EHC)
This article analyzes the historical performance of investing $1,000 in Encompass Health Corp (EHC) over different periods, detailing total returns and Compound Annual Growth Rates (CAGR). It shows that a $1,000 investment 10 years ago would be worth $3,499 today, representing a 249.9% total return. The article also provides an overview of Encompass Health Corporation, highlighting its business as the largest owner and operator of inpatient rehabilitation hospitals in the United States, its services, facilities, and financial metrics.
EHC - Encompass Health Corp Options
This article provides a detailed financial overview of Encompass Health Corp (EHC) as of July 2, 2026. It includes key financial metrics such as market cap, income, sales, EPS, and various ratios, along with stock performance data and analyst ratings. The report also highlights insider ownership, institutional ownership, and short interest percentages for EHC.
EHC - Encompass Health Corp Volatility & Greeks
This article provides a detailed overview of Encompass Health Corp (EHC) financial data, stock performance, and key metrics. It includes volatility measures, Greek values (implied through options data), insider transactions, institutional ownership, and various ratios. The data shown is current as of July 2, 2026, and highlights the company's market performance and fundamental analysis.
EHC - Encompass Health Corp Options
This article provides a detailed financial overview of Encompass Health Corp (EHC) as of July 1, 2026, including its stock performance, valuation metrics, earnings
Encompass Health Corp (EHC) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Encompass Health Corp (EHC), noting its current valuation score of 8.41, which ranks it 39th out of 76 in the Healthcare Providers & Services industry. The company's current P/E ratio is 16.43, a significant decrease from its recent high but slightly above its recent low. The article indicates that relevant data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.
Encompass Health Corp (EHC) Institutional Confidence
Encompass Health Corp (EHC) has an institutional shareholding score of 10.00, placing it first in the Healthcare Providers & Services industry. The institutional shareholding proportion has increased by 3.99% quarter-over-quarter to 102.77%. ETHSX is the largest institutional shareholder, holding 0.53% of shares outstanding.
Encompass Health (NYSE:EHC) Stock Forecast & Analyst Predictions
Encompass Health (NYSE:EHC) is projected to grow earnings by 9.6% and revenue by 7.6% annually. The company recently increased price targets from analysts, issued a dividend of US$0.19 per share, and completed a $500 million senior notes offering to refinance debt. Insider transactions show a mix of option exercises and sales, with net selling by insiders over the last 12 months.
Encompass Health Corp (EHC) Financial Health: Profitability & Balance Sheet Analysis
TradingKey provides a financial health analysis of Encompass Health Corp (EHC), ranking its financial score at 8.60 out of 76 in its industry. The report highlights EHC's weak financial status but high operating efficiency, noting a 9.01% year-over-year increase in quarterly revenue and a 28.39% increase in net profit.
Encompass Health Corp (EHC) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a detailed historical overview of Encompass Health Corp (EHC) dividends and stock splits. It lists the dates, dividend amounts, record dates, payment dates, and ex-dividend dates for numerous past and upcoming cash dividends. The content also notes that no stock split data is available for EHC.
Eastside Rehabilitation Hospital now open in Georgia
Encompass Health and Piedmont have announced the opening of Eastside Rehabilitation Hospital in Loganville, Georgia. The 40-bed inpatient rehabilitation hospital provides essential rehabilitative services for patients recovering from various serious conditions. This is Encompass Health's ninth hospital in Georgia and eighth joint venture with Piedmont, expanding access to specialized care in the region.
New rehab hospital in Loganville brings stroke and injury care closer to home
Encompass Health (NYSE: EHC) and Piedmont have opened Eastside Rehabilitation Hospital, a 40-bed inpatient facility in Loganville, Georgia, to serve patients recovering from strokes, brain injuries, and other conditions. This marks Encompass Health's ninth hospital in Georgia and eighth joint venture with Piedmont, expanding access to intensive rehabilitation services in the Gwinnett County area. The hospital offers state-of-the-art facilities, including an in-house dialysis suite and 24-hour nursing care, providing patients with a minimum of three hours of intensive therapy five days a week.
Eastside Rehabilitation Hospital now open in Georgia
Encompass Health and Piedmont have jointly opened the 40-bed Eastside Rehabilitation Hospital in Loganville, Georgia. This new facility aims to meet the increasing demand for inpatient rehabilitation services in Gwinnett County and surrounding areas, offering specialized care for various conditions. It is Encompass Health's ninth hospital in Georgia and eighth joint venture with Piedmont, expanding their network of rehabilitative services in the state.
EHC Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides an in-depth financial analysis of Encompass Health Corp (EHC), detailing its revenue streams, profitability margins, and a comparison with competitors. EHC generates a significant portion of its revenue from Medicare, showcasing strong gross, operating, and net margins. The company's financial performance is benchmarked against peers like FMS and ENSG, highlighting its substantial gross margin advantage.
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit
Encompass Health (EHC) is expanding its rehabilitation network by building a new 36-bed inpatient facility in Bridgeport, WV, which will replace a former 19-bed unit at WVU Medicine United Hospital Center. This move aligns with the company's growth strategy to increase capacity in high-demand markets, aiming to open eight new hospitals and add 150-200 beds in existing facilities in 2026. The company reaffirmed its 2023-2027 growth plans, anticipating 6-10 de novo hospitals and 80-120 bed additions annually, along with 6-8% compound annual discharge growth.
Nation’s largest rehab hospital operator plans new 36-bed facility in Bridgeport
Encompass Health Corp., the largest operator of inpatient rehabilitation hospitals, plans to build a new 36-bed facility in Bridgeport, West Virginia. This facility will be an expanded relocation of their current 19-bed unit within WVU Medicine United Hospital Center and represents a significant investment for the city, which is growing as a medical hub. The hospital will provide comprehensive rehabilitation services for patients recovering from serious injuries and illnesses, though no timeline for construction has been announced.
EHC Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Encompass Health Corp (EHC), indicating a "Strong Sell" consensus based on various technical indicators. It details momentum indicators like RSI and MACD, support and resistance levels, and analyses moving averages, all of which generally suggest a bearish outlook for the stock. The analysis highlights that EHC is trading below its 60-day and 200-day moving averages, reinforcing the negative sentiment.
Is Encompass Health’s New Bridgeport Rehab Hospital Reshaping the Investment Case for EHC?
Encompass Health Corporation (EHC) is expanding its capacity with a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing an older unit. This move aligns with the company's growth strategy, supported by raised 2026 net operating revenue guidance. While the expansion reinforces the investment narrative, investors should consider the increasing capital commitments and potential risks related to demand, costs, and reimbursement trends.
Is Encompass Health’s New Bridgeport Rehab Hospital Reshaping the Investment Case for EHC?
Encompass Health (EHC) plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing an older facility and expanding its regional footprint. This expansion aligns with the company's growth strategy, which is supported by raised 2026 revenue guidance and new hospitals planned in other states. While these developments underpin a positive growth narrative, investors should consider the increased capital commitments and potential risks associated with labor costs, capital intensity, and government reimbursement.
Encompass Health issues $500 million in senior notes due 2034
Encompass Health Corporation has announced the issuance and sale of $500 million in 5.875% senior notes due 2034. The net proceeds of approximately $491.2 million will be used to redeem $400 million of existing 4.500% senior notes due 2028 and repay $100 million under its revolving credit facility. This refinancing strategy comes as the company also plans to build a new rehabilitation hospital and has received favorable analyst ratings for its growth strategy.
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Encompass Health Corp. announced plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, which will be an expanded relocation of its former 19-bed unit at WVU Medicine United Hospital Center. The new facility will offer comprehensive rehabilitative care for various conditions, including stroke and spinal cord injuries, with state-of-the-art amenities. While under construction, Encompass Health Rehabilitation Hospital of Morgantown has expanded its capacity to ensure continuity of care for patients.
Is Encompass Health’s New Bridgeport Rehab Hospital Reshaping the Investment Case for EHC?
Encompass Health (NYSE: EHC) is expanding its capacity by building a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing an older 19-bed unit and adding advanced facilities. This expansion is part of the company's strategy to meet demand for intensive inpatient rehabilitation and is supported by raised 2026 net operating revenue guidance. While the expansion reinforces Encompass Health's growth narrative, investors should be aware of increasing capital commitments and potential risks related to demand, costs, and reimbursement trends.
Encompass Health Corporation 5.875% Senior Notes Due 2034: Indenture Details, Definitions, and SEC Filing Information
Encompass Health Corporation has issued $600 million in 5.875% Senior Notes due 2034 to refinance existing debt and for general corporate purposes. These new notes will replace $400 million of 4.50% Senior Notes due 2028 and repay up to $100 million on an existing Credit Agreement, aiming to extend the company's debt maturity profile and improve financial flexibility. The transaction is expected to be viewed positively by investors as it demonstrates proactive debt management and strengthens the company's balance sheet.
Encompass Health issues $500 million in senior notes due 2034
Encompass Health Corporation (NYSE:EHC) has completed the issuance of $500 million in 5.875% senior notes due 2034. The company plans to use the net proceeds, along with available cash, to redeem outstanding 4.500% senior notes due 2028 and repay a portion of its revolving credit facility. This refinancing strategy aligns with the company's proactive debt management and growth initiatives in the inpatient rehabilitation sector, as noted by recent analyst coverage.
Encompass Health (NYSE: EHC) issues $500M 2034 notes to refinance debt
Encompass Health Corporation issued $500 million of 5.875% Senior Notes due 2034 in a private offering, generating net proceeds of approximately $491.2 million. The company plans to use these proceeds, along with cash on hand, to redeem $400 million of its 4.500% senior notes due 2028 and repay $100 million outstanding on its revolving credit facility. This strategic move extends its debt maturity profile from 2028 to 2034 and is considered a routine capital structure management event.
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Encompass Health Corp. announced plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, expanding its previous 19-bed unit. The new facility will offer all-private rooms, a state-of-the-art therapy gym, and specialized care for various debilitating illnesses and injuries. This development aims to provide increased access to rehabilitation services for the growing local community.
New 36-bed rehab hospital coming to Bridgeport for stroke and injury patients
Encompass Health (NYSE: EHC) announced plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing its former 19-bed unit. This new facility will offer advanced therapy technologies, an in-house dialysis suite, and comprehensive rehabilitation services for patients recovering from serious illnesses and injuries. The move aims to expand access to care in the growing Bridgeport area, with temporary capacity expansion at their Morgantown hospital ensuring continuity during construction.
Encompass Health (EHC) to Establish New Rehabilitation Hospital in West Virginia
Encompass Health (EHC) announced plans to build a new 36-bed inpatient rehabilitation facility in Bridgeport, West Virginia, expanding and relocating its previous unit to enhance regional healthcare services. The company, with a market capitalization of $10.45 billion, shows strong profitability and growth with a GF Score™ of 84/100, though insider selling activity of $4.3 million in shares sold over three months warrants investor caution. The stock's P/E ratio of 17.59 is near its 3-year low, suggesting it may be fairly valued historically.
Encompass Health to build 36-bed hospital in West Virginia By Investing.com
Encompass Health Corp. announced plans to construct a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing a former 19-bed unit. This expansion aligns with the company's growth strategy, which also includes a recent $500 million senior notes offering and plans for a 50-bed hospital in Idaho. Analysts like TD Cowen and Leerink have shown positive sentiment towards Encompass Health, citing its strategic initiatives and bed additions.
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Encompass Health Corp. announced plans to construct a 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia. This new facility will replace and expand upon Encompass Health's previous 19-bed unit within WVU Medicine United Hospital Center, which has now closed. The new hospital aims to provide advanced rehabilitative care for patients recovering from various serious illnesses and injuries, serving the growing needs of the Bridgeport community.
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
Encompass Health Corp. (NYSE: EHC) announced plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia. This facility will be an expanded relocation of its former 19-bed unit and aims to increase access to specialized rehabilitative care in the region. The hospital will offer private rooms, a state-of-the-art therapy gym, and comprehensive services for patients recovering from various debilitating conditions.
TD Cowen initiates Encompass Health stock at buy on growth strategy
TD Cowen has initiated coverage on Encompass Health Corp (NYSE:EHC) with a "buy" rating and a $125 price target, citing the company's strong growth strategy in the inpatient rehabilitation industry. The firm highlights Encompass Health's ability to fund growth, dividends, and share repurchases through cash flows, and notes that InvestingPro data suggests the stock is currently undervalued. This positive outlook is further supported by recent news of a $500 million senior note offering, a raised price target from Leerink, and plans for a new 50-bed inpatient rehabilitation hospital.
TD Cowen initiates Encompass Health stock at buy on growth strategy
TD Cowen has initiated coverage on Encompass Health Corp (NYSE:EHC) with a "buy" rating and a price target of $125, citing the company's growth strategy in the inpatient rehabilitation industry. InvestingPro data supports that the stock is undervalued, with management repurchasing shares and the company trading at a P/E ratio of 17.89 and a PEG ratio of 0.74. Recent developments include a $500 million senior notes offering, a raised price target from Leerink, and plans for a new 50-bed rehabilitation hospital in Idaho.
Encompass Health, CRMC announce 40 bed inpatient rehab facility
Encompass Health Corp. and Cookeville Regional Medical Center have announced plans to build a 40-bed inpatient rehabilitation hospital on the medical center's campus in Cookeville. This new facility aims to address the growing demand for inpatient rehabilitation care in the Upper Cumberland Region, offering specialized services for patients recovering from strokes, neurological conditions, injuries, and complex orthopedic issues. The hospital will feature all private rooms, a state-of-the-art therapy gym, and a multidisciplinary care team, with an expected opening in 2027.
How Encompass Health’s (EHC) Debt Refi and Idaho Expansion Have Reframed Its Investment Story
Encompass Health (EHC) recently completed a US$500 million private offering of senior unsecured notes and plans to redeem US$400 million of existing senior notes, aiming to reshape its capital structure. Concurrently, the company announced plans for a new 50-bed inpatient rehabilitation hospital in Post Falls, Idaho, set to open in 2028, aligning its funding with its expansion strategy. This financial and operational development reinforces EHC's growth-focused investment narrative, emphasizing its ability to expand its rehabilitation network while managing labor costs and regulatory exposure.
How Encompass Health’s (EHC) Debt Refi and Idaho Expansion Have Reframed Its Investment Story
Encompass Health (EHC) recently refinanced US$500 million in senior unsecured notes and plans to redeem older debt, alongside expanding its rehabilitation network with a new 50-bed hospital in Idaho. These moves reshape the company's capital structure and reaffirm its growth strategy, though investors should monitor labor costs, reimbursement trends, and capital-intensive expansion. The article highlights that these developments reinforce Encompass Health's investment narrative focused on expanding its footprint, despite divergent fair value estimates among analysts.
Leerink raises Encompass Health stock price target on growth outlook
Leerink has increased its price target for Encompass Health Corp (NYSE:EHC) shares to $152 from $138, maintaining an Outperform rating. This adjustment reflects the company's strong growth prospects driven by historically high bed additions and de novo facilities, leading to record-high return on invested capital and over 10% year-over-year revenue growth. Leerink also anticipates diminishing risks and a positive revision path for the stock, despite recent controversies.
Encompass Health to expand Idaho presence with new 50-bed facility
Encompass Health plans to expand its presence in Idaho by constructing a new 50-bed inpatient rehabilitation hospital in Post Falls. This facility will mark Encompass Health's second inpatient rehabilitation hospital in Idaho, complementing its existing location in Boise. The Post Falls hospital aims to provide comprehensive rehabilitative services to patients recovering from various serious illnesses and injuries.
EHC6397524 Bond Price and Chart — FINRA:EHC6397524
This article provides details on the Encompass Health Corporation's EHC6397524 bond, which has a 5.875% coupon and matures on June 1, 2034. Key terms such as outstanding amount, face value, minimum denomination, and coupon frequency are outlined. The article also includes information about Encompass Health Corp., the bond's issuer, describing it as a provider of post-acute healthcare services.
Encompass Health EVP & CFO Coltharp sells $2.96m in stock
Douglas E. Coltharp, EVP and CFO of Encompass Health Corp (EHC), sold 27,694 shares of company stock for approximately $2.96 million on May 15, 2026. This sale followed his acquisition of the same number of shares through stock option exercises. Despite the sale, Coltharp maintains significant direct and indirect holdings in the company, which recently announced a $500 million senior notes offering, plans for a new inpatient rehabilitation hospital, and a quarterly dividend.
Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Encompass Health (EHC) has issued a notice for the partial redemption of its 4.500% senior notes due in 2028. This information was released via Quantisnow, a real-time market data platform that provides alerts on financial news to its subscribers.
AlphaCore Capital LLC Invests $4.88 Million in Encompass Health Corporation $EHC
AlphaCore Capital LLC initiated a new position in Encompass Health Corporation (NYSE:EHC), purchasing 45,991 shares valued at approximately $4.88 million in the fourth quarter. Analysts maintain a "Buy" consensus for EHC, forecasting solid earnings for the current fiscal year with an average target price of $144.17. The company recently exceeded quarterly expectations, reporting diluted EPS of $1.60 and revenue of $1.59 billion, and declared a quarterly dividend of $0.19 per share.
Encompass Health Announces New Senior Notes Offering
Encompass Health announced a private offering of $500 million in 5.875% senior unsecured notes due 2034. The company plans to use the proceeds to redeem outstanding 2028 notes and repay a portion of its revolving credit facility, aiming to extend its debt maturity profile and re-balance its capital structure. The move is expected to enhance financial flexibility and provide clarity for bondholders.
Encompass Health Corporation (NYSE:EHC) Receives Average Recommendation of "Buy" from Analysts
Encompass Health Corporation (NYSE:EHC) has received an average "Buy" recommendation from analysts, with a 12-month target price of approximately $144.17. The company recently reported strong quarterly results, beating EPS and revenue expectations, and raised its FY 2026 EPS guidance. Despite some insider selling, institutional investors have increased their holdings, indicating mixed but generally positive sentiment.
Encompass Health To Issue $500 Million 5.875% Senior Notes Due 2034
Encompass Health (EHC) plans to issue $500 million of 5.875% senior notes due 2034 through a private offering, with Wells Fargo Securities acting as the representative for initial purchasers. The company intends to use the proceeds, combined with cash, to redeem $400 million of existing notes due 2028, repay $100 million on its revolving credit facility, and cover associated fees. The offering is anticipated to close around May 29, 2026.
Encompass Health (NYSE: EHC) prices $500M 5.875% senior notes due 2034
Encompass Health (NYSE: EHC) has priced a private offering of $500 million in 5.875% senior notes due 2034. The company plans to use the net proceeds, along with cash on hand, to redeem $400 million of its outstanding 4.500% Senior Notes due 2028 and repay $100 million under its revolving credit facility. The offering is expected to close around May 29, 2026, and the notes will be guaranteed by certain subsidiaries.
[144] Encompass Health Corp SEC Filing
This article reports on an SEC Form 144 filing by Encompass Health Corp (EHC) on May 15, 2026, detailing a proposed sale of 27,694 shares of common stock with an aggregate market value of $2,958,629.19. The shares are to be sold by an unnamed individual, acquired through a stock option exercise, through UBS Financial Services Inc. The filing indicates a "Neutral" impact and sentiment.
Encompass Health announces private offering of senior notes
Encompass Health Corp. announced a private offering of $500 million in senior notes maturing in 2034. The net proceeds will be used to redeem $400 million of existing 4.500% Senior Notes due 2028 and repay $100 million of its revolving credit facility. The offering is subject to market and other conditions.
Encompass Health to pay off $400M of 2028 debt in June
Encompass Health (NYSE:EHC) announced its plan to redeem $400 million of its 4.500% senior notes due 2028. The redemption will occur at 100% of par plus accrued interest, with payment expected on June 15, 2026. This action is anticipated to result in a $3.2 million loss on early extinguishment of debt in Q2 2026, leaving $400 million of these notes outstanding.
Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Encompass Health Corp. has announced a partial redemption of $400 million of its 4.500% senior notes due 2028. The redemption price will be 100.0% of par plus accrued interest, with payment expected on June 15, 2026. This action is anticipated to result in an approximate $3.2 million loss on early extinguishment of debt in the second quarter of 2026 for the company.
Encompass Health prices $500M debt to redeem 2028 notes, repay loan
Encompass Health (NYSE: EHC) has priced a private offering of $500 million in 5.875% senior notes due 2034, with an expected closing date of May 29, 2026. The proceeds will be used to redeem $400 million of its 4.500% senior notes due 2028 and repay $100 million outstanding on its senior secured revolving credit facility, along with associated fees. This move aims to refinance existing debt and extend the company's debt maturity profile.
